Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.
D000328:Adult; D000568:Amenorrhea / Q000503:physiopathology; D000735:Androstenedione / Q000097:blood; D002369:Castration; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000097:blood / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005246:Feedback; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007006:Hypogonadism / Q000503:physiopathology; D007031:Hypothalamus / Q000502:physiology; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008598:Menstruation; D010053:Ovary / Q000502:physiology; D010902:Pituitary Gland / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000503:physiopathology; D011863:Radioimmunoassay; D013739:Testosterone / Q000097:blood; D013997:Time Factors; D014424:Turner Syndrome / Q000503:physiopathology
D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D000735:Androstenedione; D004997:Ethinyl Estradiol; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone